Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 3 March

Sophia Mavridis
March 3, 2022

Morning Bell 2 March

Sophia Mavridis
March 2, 2022

Morning Bell 1 March

Sophia Mavridis
March 1, 2022

Morning Bell 28 February

Sophia Mavridis
February 28, 2022

Weekly Wrap 25 February

Sophia Mavridis
February 25, 2022

Morning Bell 24 February

Paulina Peters
February 24, 2022

Morning Bell 23 February

Sophia Mavridis
February 23, 2022

Morning Bell 22 February

Paulina Peters
February 22, 2022

Morning Bell 21 February

Sophia Mavridis
February 21, 2022

Weekly Wrap 18 February

Sophia Mavridis
February 18, 2022